Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Children's Oncology Group
Case Comprehensive Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
Fred Hutchinson Cancer Center
Tufts Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital